UA96426C2 - Isolated human or humanized antibody that specifically binds to il-13 - Google Patents
Isolated human or humanized antibody that specifically binds to il-13Info
- Publication number
- UA96426C2 UA96426C2 UAA200804983A UAA200804983A UA96426C2 UA 96426 C2 UA96426 C2 UA 96426C2 UA A200804983 A UAA200804983 A UA A200804983A UA A200804983 A UAA200804983 A UA A200804983A UA 96426 C2 UA96426 C2 UA 96426C2
- Authority
- UA
- Ukraine
- Prior art keywords
- specifically binds
- isolated human
- humanized antibody
- antibody
- isolated
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention relates to an isolated human antibody that specifically binds to IL-13, and to a pharmaceutical composition comprising the antibody.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0521509A GB0521509D0 (en) | 2005-10-21 | 2005-10-21 | Organic molecules |
Publications (1)
Publication Number | Publication Date |
---|---|
UA96426C2 true UA96426C2 (en) | 2011-11-10 |
Family
ID=35458484
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200804983A UA96426C2 (en) | 2005-10-21 | 2006-10-19 | Isolated human or humanized antibody that specifically binds to il-13 |
Country Status (5)
Country | Link |
---|---|
CN (1) | CN101287760B (en) |
GB (1) | GB0521509D0 (en) |
TN (1) | TNSN08175A1 (en) |
UA (1) | UA96426C2 (en) |
ZA (1) | ZA200802541B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106749674A (en) * | 2016-12-23 | 2017-05-31 | 四川大学 | A kind of new asthma polypeptide vaccine and preparation method thereof |
CN109776677B (en) * | 2017-11-15 | 2023-11-03 | 尚华科创投资管理(江苏)有限公司 | Humanized anti-IL-13 antibody and preparation method and application thereof |
-
2005
- 2005-10-21 GB GB0521509A patent/GB0521509D0/en not_active Ceased
-
2006
- 2006-10-19 UA UAA200804983A patent/UA96426C2/en unknown
- 2006-10-19 CN CN2006800374681A patent/CN101287760B/en not_active Expired - Fee Related
-
2008
- 2008-03-19 ZA ZA200802541A patent/ZA200802541B/en unknown
- 2008-04-18 TN TNP2008000175A patent/TNSN08175A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200802541B (en) | 2009-10-28 |
CN101287760B (en) | 2012-10-17 |
GB0521509D0 (en) | 2005-11-30 |
TNSN08175A1 (en) | 2009-10-30 |
CN101287760A (en) | 2008-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20181218T1 (en) | Humanized anti-il-6 antibodies, compositions, methods and uses | |
HRP20181459T1 (en) | Humanized anti-beta7 antagonists and uses thererfor | |
TW200732349A (en) | Anti-OX40L antibodies and methods using same | |
UA101487C2 (en) | Humanized b-ly1 antibody formulation | |
WO2008060705A3 (en) | Anti-dll4 antibodies and methods using same | |
TW200626171A (en) | Fixed dosing of HER antibodies | |
IL199216A (en) | Monoclonal antibodies against angptl3, pharmaceutical compositions comprising the same and uses thereof | |
WO2007130697A8 (en) | Anti-ephb4 antibodies and methods using same | |
WO2006083936A3 (en) | Anti-ephb2 antibodies and methods using same | |
TW200738751A (en) | Anti-EphrinB2 antibodies and methods using same | |
UA94211C2 (en) | Isolated fully human monoclonal anti-cd3 antibody | |
UA96426C2 (en) | Isolated human or humanized antibody that specifically binds to il-13 | |
UA98100C2 (en) | Humanized monoclonal antibody that binds and neutralizes human nogo | |
WO2007002096A3 (en) | Methods and compositions for targeting ifnar2 | |
UA98927C2 (en) | Sclerostin binding antibody or fragment thereof |